Poitiers, France

Renaud Robert

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Université De Poitiers. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Renaud Robert. Retrieved from https://idiyas.com/inventor/renaud-robert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Renaud Robert: Innovator in Smooth Muscle Cell Constriction Treatment

Introduction

Renaud Robert is a notable inventor based in Poitiers, France. He has made significant contributions to the field of medical treatments, particularly focusing on conditions related to smooth muscle cell constriction. His innovative work has the potential to impact the treatment of various diseases.

Latest Patents

Renaud Robert holds a patent for the "Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction." This invention addresses critical health issues such as hypertension and asthma, providing a new avenue for therapeutic intervention.

Career Highlights

Throughout his career, Renaud Robert has been associated with esteemed institutions, including Université de Poitiers and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Renaud has collaborated with notable colleagues, including Laurence Pignoux and Frédéric Becq. These partnerships have enriched his research and fostered innovation in his field.

Conclusion

Renaud Robert's contributions to the treatment of diseases linked to smooth muscle cell constriction highlight his role as an influential inventor. His patent and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…